Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT01319695

Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone (FSH) in Ovarian Stimulation of Women Undergoing in Vitro Fertilisation

Sponsor: National and Kapodistrian University of Athens

Interventions corifollitropin alfa recombinant follicle stimulating hormone (FSH)

Updated 8 times since 2017 Last updated: Mar 15, 2021 Started: Jan 31, 2011 Primary completion: Jul 31, 2016 Completion: Aug 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Infertility, this trial is completed. The trial is conducted by National and Kapodistrian University of Athens and has accumulated 8 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Apr 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jan 2021 — Apr 2021 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

Status: Unknown Status → Completed

▶ Show 3 earlier versions

May 2018 — Jun 2018 [monthly]

Unknown Status PHASE1_PHASE2

Status: Recruiting → Unknown Status
Feb 2017 — May 2018 [monthly]

Recruiting PHASE1_PHASE2
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE1_PHASE2

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National and Kapodistrian University of Athens

Data source: National and Kapodistrian University of Athens

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Athens, Greece